2-Thiophenecarboxylic acid, 3-[[[2-methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-, methyl ester
| Title | Journal |
|---|---|
| Perfluorooctanoate suppresses spheroid attachment on endometrial epithelial cells through peroxisome proliferator-activated receptor alpha and down-regulation of Wnt signaling. | Reproductive toxicology (Elmsford, N.Y.) 20131201 |
| Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication. | Bioorganic & medicinal chemistry letters 20130901 |
| Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer. | The Journal of biological chemistry 20121102 |
| (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties. | Journal of medicinal chemistry 20120322 |
| Development of improved PPARβ/δ inhibitors. | ChemMedChem 20120102 |
| Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo. | PloS one 20120101 |
| High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties. | Molecular pharmacology 20111101 |
| Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice. | Journal of clinical biochemistry and nutrition 20110701 |
| Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation. | Acta pharmacologica Sinica 20110501 |
| The decreased expression of peroxisome proliferator-activated receptors delta (PPARdelta) is reversed by digoxin in the heart of diabetic rats. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100801 |
| Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury. | The Journal of pharmacology and experimental therapeutics 20100501 |
| Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. | Endocrinology 20100401 |
| Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist. | Journal of medicinal chemistry 20100225 |
| Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway. | The Journal of pharmacology and experimental therapeutics 20100201 |
| Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. | Molecular endocrinology (Baltimore, Md.) |